Background: Ureteral rest refers to the removal of hardware across a ureteral stricture, allowing for stricture maturation and stabilization, before ureteral reconstruction. Objectives: We aimed to assess the potential impact of ureteral rest on lower urinary tract symptoms (LUTS) and health-related quality of life (HRQOL) in patients undergoing ureteral rest. Design: Prospective, longitudinal, self-controlled study Methods: We included patients undergoing ureteral reconstruction between April 2022 and April 2025. We defined ureteral rest as replacing an indwelling double-J stent (DJS) with a percutaneous nephrostomy tube (PCN) prior to ureteral reconstruction. Primary outcomes were patient-reported LUTS (via International Prostate Symptom Score) and HRQOL (via Patient-Reported Outcomes Measurement Information System 29 v2.0). The secondary outcome was the incidence of urinary tract infections (UTIs). Questionnaires were completed prior to initiating ureteral rest (with a DJS) and after at least 3 weeks of ureteral rest (with a PCN). Continuous and categorical variables were compared using paired t-tests and chi-squared tests, respectively. Results: Thirty-five patients met our study’s inclusion criteria. With regard to LUTS, patients undergoing ureteral rest were found to have reduced urinary frequency ( p = 0.001), straining ( p = 0.03), and urgency ( p = 0.0002). With regard to HRQOL, patients undergoing ureteral rest were found to have improved sleep disturbance ( p = 0.04). There was no difference in UTI rates before and after ureteral rest ( p = 0.48). Conclusion: Patients undergoing ureteral rest prior to ureteral reconstruction may experience improvements in LUTS without compromising HRQOL outcomes or increasing the risk of UTIs.
Rosenfeld et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: